Filana Therapeutics, Inc. (FLNA)
1.955
-0.04
(-1.76%)
USD |
NASDAQ |
Mar 16, 16:00
1.97
+0.02
(+0.77%)
After-Hours: 20:00
Filana Therapeutics Total Liabilities (Quarterly) : 43.95M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| cbdMD, Inc. | 2.774M |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Amicus Therapeutics, Inc. | 675.63M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Spero Therapeutics, Inc. | 27.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 118.36M |
| Shareholders Equity (Quarterly) | 74.40M |
| Current Ratio | 2.229 |